TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
RVMD

Revolution Medicines Inc

Healthcare · Biotechnology

190.70$ -1.1% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RVMD
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
+1,031.4% +29.3% +157.3% +30.1% +10.0% +153.9% +24.1% -8.0%
+804.9% +56.8% +238.9% +29.9% +11.9% +184.7% +23.9% -10.9%
+666.5% -76.1% +525.9% +4.1% +48.8% +331.3% -22.0% -29.3%
+666.5% +76.4% +259.0% +30.9% +11.8% +187.3% +23.5% -11.5%
+19.6% -26.8% -7.3% -21.2% -73.2% -100.0%
-100.0% +0.0%
+30.8% +4.0% +24.6% +700.2% +3.5%
+0.0% +0.0% +0.0% +0.0% +0.0% +0.0% +0.0%
-1.7% -1.7% -1.8% -1.8% -1.8% -1.9% -1.5%
+601.0% -8.0% +36.4% +46.0% -6.4% +85.8% +24.5% +146.7%
+302.1% +40.9% +9.6% +27.9% +2.7% +132.1% +13.9% +77.2%
+36.1% +1,736.0% +69.2% +9.0% +8.8% +74.7% +27.9%
+56.2% +117.7% +10.6% +11.5% +51.6% +190.0% -11.9% +18.7%
+2,033.3% +57.8% +211.2% +26.9% +13.7% +166.5% +24.0% -28.0%
+0.0% +0.0% +82.6% +9.3% +10.7% +40.3% +48.2% +13.3%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?